{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:18:15Z","timestamp":1790720295485,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> In recent years, gallstones have become a major condition affecting people\u2019s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> To investigate the effects of tauroursodeoxycholic acid (TUDCA) and\/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group \u2160 (TUDCA, 24 cases), group \u2161 (intestinal probiotics, 24 cases), group \u2162 (TUDCA and intestinal probiotics, 24 cases) and group \u2163 (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention (<jats:italic>p<\/jats:italic> &amp;lt; 0.05), but the serum LDL-C level in group \u2162 before and after the intervention was similar (<jats:italic>p<\/jats:italic> &amp;gt; 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III (<jats:italic>p<\/jats:italic> &amp;gt; 0.05), and the differences between the other two groups were statistically significant (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and \u2162 (<jats:italic>p<\/jats:italic> &amp;gt; 0.05), and the differences between the other two groups were statistically significant (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). There were significant differences in the levels of free Ca<jats:sup>2+<\/jats:sup>, pH value and glycoprotein in bile among the four groups (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). The level of lithocholic acid (LCA) in groups \u2161 and \u2162 was similar, as was the level of LCA in groups I and \u2160V, but the difference in level between the other two groups was statistically significant (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The combination of TUDCA and intestinal probiotics did not enhance the effect of either treatment. The use of intestinal probiotics alone can maximise the reverse development of bile composition in patients with cholecystolithiasis compared with TUDCA alone and a combination of TUDCA and intestinal probiotics, thereby reducing gallstone formation.<\/jats:p>","DOI":"10.3389\/fphar.2022.882764","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:23:36Z","timestamp":1666596216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of oral tauroursodeoxycholic acid and\/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Fan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YeFeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1194\/jlr.R900011-JLR200","article-title":"Bile acids:regulation of apoptosis by ursodeoxycholic acid","volume":"104","author":"Amaral","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF02913334","article-title":"An extended chemical analysis of gallstone","volume":"22","author":"Chandran","year":"2007","journal-title":"Indian J. Clin. biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver diseaseand potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"716654","DOI":"10.3389\/fphys.2021.716654","article-title":"Changes and correlations of the intestinal flora and liver metabolite profiles in mice with gallstones","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","article-title":"Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules","volume":"104","author":"Copple","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"28938","DOI":"10.4161\/pri.28938","article-title":"The therapeutic potential of chemical chaperones in protein folding diseases","volume":"8","author":"Cortez","year":"2014","journal-title":"Prion"},{"key":"B7","doi-asserted-by":"publisher","first-page":"G1171","DOI":"10.1152\/ajpgi.00360.2007","article-title":"A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine","volume":"294","author":"de Vogel-van den Bosch","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"s4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile Acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"G912","DOI":"10.1152\/ajpgi.00479.2005","article-title":"Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids","volume":"290","author":"Frankenberg","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/microorganisms8060835","article-title":"Gallstone disease and microbiome","volume":"8","author":"Grigor'eva","year":"2020","journal-title":"Microorganisms"},{"key":"B13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/s0022-2275(20)41426-9","article-title":"Bile acid solubility and precipitation in vitro and in vivo: The role of conjugation, pH, and Ca2+ ions","volume":"33","author":"Hofmann","year":"1992","journal-title":"J. Lipid Res."},{"key":"B14","first-page":"191","article-title":"Enterohepatic circulation of cholesterol: The role of the liver and small intestine in gallstone formation","volume":"22","author":"Jiang","year":"2017","journal-title":"J. Surg. Concepts Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejps.2009.01.006","article-title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","volume":"37","author":"Khan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: The FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.suc.2008.07.009","article-title":"Lithogenesis and bile metabolism","volume":"88","author":"Lambou-Gianoukos","year":"2008","journal-title":"Surg. Clin. North Am."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100289","DOI":"10.1016\/j.aohep.2020.100289","article-title":"The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation","volume":"23","author":"Lu","year":"2021","journal-title":"Ann. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.sla.0000094305.77843.cf","article-title":"gallstone formation prophylaxis after gastric restrictive procedures for weight loss: A randomized double-blind placebo-controlled trial","volume":"238","author":"Miller","year":"2003","journal-title":"Ann. Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.148.3675.1339","article-title":"Gallstones produced experimentally by lithocholic acid in rats","volume":"148","author":"Palmer","year":"1965","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3969\/j.issn.1006-1533.2017.16.002","article-title":"Analysis of gallbladder stone relevant bile and its clinical research progress","volume":"38","author":"Qiao","year":"2017","journal-title":"Shanghai Med. Pharm. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3877\/cma.j.issn.1674-1358.2019.06.002","article-title":"Research progress of Lactobacillus and liver disease","volume":"13","author":"Quan","year":"2019","journal-title":"Chin. J. Exp. Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/19490976.2019.1618173","article-title":"The 'in vivo lifestyle' of bile acid 7\u03b1-dehydroxylating bacteria: Comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice","volume":"11","author":"Ridlon","year":"2020","journal-title":"Gut Microbes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0002-9610(99)80115-9","article-title":"A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss","volume":"169","author":"Sugerman","year":"1995","journal-title":"Am. J. Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00535-016-1289-7","article-title":"Evidence-based clinical practice guidelines for cholelithiasis 2016","volume":"52","author":"Tazuma","year":"2017","journal-title":"J. Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/labinvest.2017.6","article-title":"Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis","volume":"97","author":"Van den Bossche","year":"2017","journal-title":"Lab. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e02766","DOI":"10.1128\/AEM.02766-16","article-title":"Ursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice","volume":"83","author":"Van den Bossche","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7453\/gahmj.2014.017","article-title":"The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases","volume":"3","author":"Vang","year":"2014","journal-title":"Glob. Adv. Health Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gtc.2010.02.010","article-title":"Pathogenesis of gallstones","volume":"39","author":"Venneman","year":"2010","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M072819","article-title":"Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota","volume":"58","author":"Wahlstr\u00f6m","year":"2017","journal-title":"J. Lipid Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.11952\/j.issn.1007-1954.2020.01.002","article-title":"Intestinal flora is involved in gallbladder cholesterol stone formation by affecting bile acid metabolism","volume":"32","author":"Wang","year":"2020","journal-title":"J. Hepatopancreatobiliary Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1381\/096089293765559278","article-title":"A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty","volume":"3","author":"Williams","year":"1993","journal-title":"Obes. Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12876-020-01512-8","article-title":"Changes in plasma bile acids are associated with gallbladder stones and polyps","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genomics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1111\/bph.14705","article-title":"Ursodeoxycholic acid accelerates bile acid enterohepatic Circulation","volume":"176","author":"Zhang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1677\/JOE-09-0271","article-title":"Liver X receptor in cholesterol metabolism","volume":"204","author":"Zhao","year":"2010","journal-title":"J. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.5301\/jbm.5000173","article-title":"Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps","volume":"31","author":"Zhao","year":"2016","journal-title":"Int. J. Biol. Markers"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.882764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:23:41Z","timestamp":1666596221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.882764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":43,"alternative-id":["10.3389\/fphar.2022.882764"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.882764","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"882764"}}